Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility

Name: Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement to a new drug submission (SNDS) that meets specific eligibility conditions. Sponsors nearing the end of clinical development of a drug can apply to Health Canada for rolling review status for a forthcoming drug submission.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-09-01

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility (French, HTML) HTML
Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility (English, HTML) HTML

Related open data

Health Canada